entity

DAM transition

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DAM transition: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections
3Hypotheses
3Analyses
0Outgoing
3Incoming
4Experiments
5Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (3)

SourceRelationTypeStr
TREM2 R47H variantinhibitsgene0.90
TREM2regulatesprotein0.90
TREM2 loss-of-functionimpairsgene0.70

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima 0.862 neurodegeneration Variant Annotation and Prioritization of
HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM 0.605 neurodegeneration How do different microglial subtypes (DA
Microglial Priming Window for HDAC1-Dependent DAM Transition 0.463 neurodegeneration What is the optimal therapeutic window d

Mentioning Analyses (3)

Scientific analyses that reference this entity

What are the optimal timing windows for TREM2 inhibition vs activation in Alzhei

neurodegeneration | 2026-04-11 | 0 hypotheses

Gap 006 analysis (archived stub)

neurodegeneration | 2026-04-02 | 7 hypotheses Top: 0.760

TREM2 agonism vs antagonism in DAM microglia

neurodegeneration | 2026-04-01 | 6 hypotheses Top: 0.886

Experiments (4)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
NAD depletion effects on monocyte/macrophage differentiation exploratory Inflammatory bowel disease 0.900 0.00 Primary mouse and human monocy proposed N/A
FK866 treatment in DSS-induced colitis mouse model validation Inflammatory bowel disease (co 0.900 0.00 DSS-induced colitis mice proposed N/A
FK866 in azoxymethane/DSS colitis-associated cancer model validation Colitis-associated cancer 0.850 0.00 AOM/DSS-treated mice proposed N/A
FK866 mechanism validation in Rag1-/- mice validation Inflammatory bowel disease 0.850 0.00 Rag1-/- mice with DSS-induced proposed N/A

Related Papers (5)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Multiple Sclerosis Pathology. [PMID:29358320] Lassmann H Cold Spring Harbor perspective 2018 0

Debates (5)

Multi-agent debates referencing this entity

Hypothesis debate: PLCG2 Allosteric Modulation as a Precision Therapeutic for TR

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: PLCG2 Allosteric Modulation as a Precision Therapeutic for TR

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Analysis for knowledge gap 006 in the neurodegeneration domain.

closed · Rounds: 4 · Score: 0.79 · 2026-04-22

The debate proposed temporal TREM2 modulation but couldn't define when to switch

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

The disease-associated microglia (DAM) phenotype involves TREM2 upregulation, bu

closed · Rounds: 4 · Score: 0.57 · 2026-04-01

Related Research

Hypotheses and analyses mentioning DAM transition in their description or question text

No additional research found